Monitoring the Session

HB 444

Relating to the amount a pharmacy benefit manager may reimburse a pharmacist or pharmacy for a prescription drug.

Filed

Verdict: No flags

No flagsInitial review
Rep. Armando "Mando" MartinezDHouse 39

Initial review · graded Nov 9, 2026 · How we grade

Caption

relating to the amount a pharmacy benefit manager may reimburse a pharmacist or pharmacy for a prescription drug.

Caption from analyzed text · version I.

Summary

The bill sets two floors on what pharmacy benefit managers can pay pharmacists and pharmacies for prescription drugs.

The bill sets two floors on what pharmacy benefit managers can pay pharmacists and pharmacies for prescription drugs. First, a benefit manager may not pay an independent pharmacy less than it pays its own affiliated pharmacy for the same service. Second, no pharmacy may be paid less than the national average acquisition cost of the drug, starting September 1, 2027.

Receipt

The receipt

90R-HB444 · 2026-11-09

SOLD BY

ITEM

relating to the amount a pharmacy benefit manager may reimburse a pharmacist or pharmacy for a prescription drug.

WHAT IT DOES

The bill sets two floors on what pharmacy benefit managers can pay pharmacists and pharmacies for prescription drugs.

The bill sets two floors on what pharmacy benefit managers can pay pharmacists and pharmacies for prescription drugs. First, a benefit manager may not pay an independent pharmacy less than it pays its own affiliated pharmacy for the same service. Second, no pharmacy may be paid less than the national average acquisition cost of the drug, starting September 1, 2027.

CHARGES

[ ] NONE FOUND

TOTAL

No fiscal note in the loaded record.

HISTORY

  1. Filed
FILED UNDER

No verified beat found.

No flags

THANK YOU FOR CHECKING THE RECEIPT

CAMPAIGN PAID FOR BY

CAMPAIGN PAID FOR BY

Donors

Not tied to this bill.

Sources

The author's campaign account only. Own money and internal transfers are separate on the member page.

Derived itemized flow · Oct 28, 2024 to Jun 26, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Border Health PAC$10,000.00

Border Health PAC

$10,000.00

Cash
$10,000.00
Paid by others
$0.00
Total
$10,000.00

Also funds 17 other sitting lawmakers.

Derived recipient stock · Oct 28, 2024 to Aug 26, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · on Nov 26, 2025. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101026922.

Marc Rodriguez$9,500.00
Texas Trial Lawyers Association PAC$9,000.00

Texas Trial Lawyers Association PAC

$9,000.00

Cash
$9,000.00
Paid by others
$0.00
Total
$9,000.00

Also funds 137 other sitting lawmakers.

Derived recipient stock · Jul 24, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Dec 10, 2024 to Apr 8, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100979779, 101026922, 101055340.

Money

Missing data does not establish zero giving. Display amounts are rounded.

×

Border Health PAC

$10,000.00

Cash
$10,000.00
Paid by others
$0.00
Total
$10,000.00

Also funds 17 other sitting lawmakers.

Derived recipient stock · Oct 28, 2024 to Aug 26, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · on Nov 26, 2025. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101026922.

×

Texas Trial Lawyers Association PAC

$9,000.00

Cash
$9,000.00
Paid by others
$0.00
Total
$9,000.00

Also funds 137 other sitting lawmakers.

Derived recipient stock · Jul 24, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Dec 10, 2024 to Apr 8, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100979779, 101026922, 101055340.

Votes

No floor vote loaded for this bill.

Fiscal

No fiscal note in the loaded record.

How this was graded

Analysis of text version I by a super-expensive superintelligence, Nov 9, 2026, against the published rubric.

Sources

Texas House · Filed Nov 9, 2026

11/09/2026 H Filed

Texas Legislature Online · Introduced

Data snapshot Nov 10, 2026 at 2:33 AM CST. Grades, charges, quotes and corrections follow the published record.

Subjects

Health Care Providers

Human Services--Medical Assistance

Insurance--Health & Accident

Text

The text as introduced · 184 words

90R4190 SCF-D

By: Martinez
H.B. No. 444

A BILL TO BE ENTITLED

AN ACT

relating to the amount a pharmacy benefit manager may reimburse a

pharmacist or pharmacy for a prescription drug.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. The heading to Section 1369.604, Insurance Code,

is amended to read as follows:

Sec. 1369.604. REIMBURSEMENT OF [ AFFILIATED AND

NONAFFILIATED ] PHARMACISTS AND PHARMACIES.

SECTION 2. Section 1369.604, Insurance Code, is amended by

amending Subsection (b) and adding Subsection (c) to read as

follows:

(b) A pharmacy benefit manager may not pay [ an affiliated

pharmacist or pharmacy a reimbursement amount that is more than the

amount the pharmacy benefit manager pays ] a nonaffiliated

pharmacist or pharmacy an amount that is less than the amount the

pharmacy benefit manager pays an affiliated pharmacist or pharmacy

for the same pharmacist service.

(c) A pharmacy benefit manager may not reimburse a

pharmacist or pharmacy at an amount that is less than the national

average drug acquisition cost of the drug.

SECTION 3. This Act takes effect September 1, 2027.